Publicaciones Científicas
Roadmap to cure multiple myeloma
Rodriguez-Otero, P; Paiva, B; San-Miguel, JF
Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma
Puig, N; Flores-Montero, J; Burgos, L; Cedena, MT; Cordon, L; Perez, JJ; Sanoja-Flores, L; Manrique, I; Rodriguez-Otero, P; Rosinol, L; Martinez-Lopez, J; Mateos, MV; Lahuerta, JJ; Blade, J; San…
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development
Alameda, D; Goicoechea, I; Vicari, M; Arriazu, E; Nevone, A; Rodriguez, S; Lasa, M; Puig, N; Cedena, MT; Alignani, D; Garate, S; Lara-Astiaso, D; Vilas-Zornoza, A; Sarvide, S; Ocio, EM; Lecumberri, R…
The Current Role of the Heavy/Light Chain Assay in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma: An Evidence-Based Approach
Rios-Tamayo, R; Puig, N; Algarin, M; Silva, JLGD; Barbosa, N; Encinas, C; Hernandez, JA; Alonso, R; Campos, ML; Rodriguez, T; Leivas, A; Olivares, MJ; Sanchez, MJ; Paiva, B; Lahuerta, JJ; Martinez…
Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change?
Jimenez-Ubieto, A; Paiva, B; Puig, N; Cedena, MT; Martinez-Lopez, J; Oriol, A; Blanchard, MJ; Rios, R; Martin, J; Martinez, R; Sureda, A; Hernandez, MT; de la Rubia, J; Krnisk, I; Cabanas, V;…
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
De Larrea, CF; Kyle, R; Rosinol, L; Paiva, B; Engelhardt, M; Usmani, S; Caers, J; Gonsalves, W; Schjesvold, F; Merlini, G; Lentzch, S; Ocio, E; Garderet, L; Moreau, P; Sonneveld, P; Badros, A;…
Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients
Janusz, K; Izquierdo, MM; Cadenas, FL; Ramos, F; Sanchez, JMH; Lumbreras, E; Robledo, C; del Real, JS; Caballero, JC; Collado, R; Bernal, T; Pedro, C; Insunza, A; de Paz, R; Xicoy, B; Salido, E;…
Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival
Cabezon, M; Malinverni, R; Bargay, J; Xicoy, B; Marce, S; Garrido, A; Tormo, M; Arenillas, L; Coll, R; Borras, J; Jimenez, MJ; Hoyos, M; Valcarcel, D; Escoda, L; Vall-Llovera, F; Garcia, A; Font, LL;…
Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study
Pleyer, L; Leisch, M; Kourakli, A; Padron, E; Maciejewski, JP; Cirici, BX; Kaivers, J; Ungerstedt, J; Heibl, S; Patiou, P; Hunter, AM; Mora, E; Geissler, K; Dimou, M; Lorenzo, MJJ; Melchardt, T; Egle…